Vivid Vision Inc

Vivid Vision Inc develops digital vision care solutions for diagnosis and therapeutic training of binocular vision disorders and visual field assessment. The company manufactures two core platforms: Vivid Vision (VV), an advanced vision training system for amblyopia, strabismus, and convergence insufficiency delivered via VR-based home training; and Vivid Vision Perimetry (VVP), a precision at-home microperimetry system for clinical visual field testing in retinal and glaucoma disorders. VVP is validated for use as a functional vision endpoint in clinical trials for geographic atrophy, age-related macular degeneration, and glaucoma therapeutics. The company also offers EYEBAB VT, a therapeutic exercise platform with dozens of vision activities for clinic-based intervention. With over 100,000 patients in 50+ countries since 2014, Vivid Vision systems are used by major ophthalmic pharmaceutical companies and leading research institutions. Published studies demonstrate VVP achieves 6.8× better precision than standard automated perimetry, 2× better fixation stability, and 99% adherence to at-home testing protocols. The platform has been evaluated by premier institutions including the Retina Foundation of the Southwest and Duke University Medical Center. Vivid Vision Perimetry is clinically validated and industry-ready for phase I and II ophthalmology trials.